Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

A comparison of body condition of the yellowstriped butterfish Labracoglossa argenteiventris in relation to parasitism by the cymothoid isopod Ceratothoa arimae.

Kawanishi R, Kohya N, Sogabe A, Hata H.

Parasitol Int. 2019 Oct;72:101932. doi: 10.1016/j.parint.2019.101932. Epub 2019 May 23.

PMID:
31129198
2.

A Case of Signet Ring Cell Carcinoma of the Gallbladder Which Was Treated by Aggressive Surgery and Intensive Adjuvant Chemotherapy.

Hiraki M, Ueda J, Kai K, Ide T, Asai M, Ohtsuka T, Kohya N, Mukai S, Kitahara K, Noshiro H.

J Gastrointest Cancer. 2017 Mar;48(1):83-86. doi: 10.1007/s12029-016-9804-x. No abstract available.

PMID:
26825388
3.

A case of unclassified multicystic biliary tumor with biliary adenofibroma features.

Kai K, Yakabe T, Kohya N, Miyoshi A, Iwane S, Mizuta T, Miyazaki K, Tokunaga O.

Pathol Int. 2012 Jul;62(7):506-10. doi: 10.1111/j.1440-1827.2012.02830.x. Epub 2012 May 10.

PMID:
22726072
4.

Tumor budding and dedifferentiation in gallbladder carcinoma: potential for the prognostic factors in T2 lesions.

Kai K, Kohya N, Kitahara K, Masuda M, Miyoshi A, Ide T, Tokunaga O, Miyazaki K, Noshiro H.

Virchows Arch. 2011 Oct;459(4):449-56. doi: 10.1007/s00428-011-1131-9. Epub 2011 Jul 22.

PMID:
21785869
5.

Outcomes of patients with spontaneous rupture of hepatocellular carcinoma.

Miyoshi A, Kitahara K, Kohya N, Noshiro H, Miyazahi K.

Hepatogastroenterology. 2011 Jan-Feb;58(105):99-102.

PMID:
21510294
6.

Gallbladder carcinoma with a large monolocular cystic cancerous component.

Hiraki M, Yakushiji H, Hashiguchi K, Harada S, Kohya N, Kai K, Yamaguchi K, Mori D, Irie K, Tokunaga O, Noshiro H, Miyazaki K.

Oncol Lett. 2010 Nov;1(6):995-998. Epub 2010 Sep 23.

7.

Ribonucleotide reductase subunit M1 assessed by quantitative double-fluorescence immunohistochemistry predicts the efficacy of gemcitabine in biliary tract carcinoma.

Nakamura J, Kohya N, Kai K, Ohtaka K, Hashiguchi K, Hiraki M, Kitajima Y, Tokunaga O, Noshiro H, Miyazaki K.

Int J Oncol. 2010 Oct;37(4):845-52.

PMID:
20811706
8.

Rational therapeutic strategy for T2 gallbladder carcinoma based on tumor spread.

Kohya N, Kitahara K, Miyazaki K.

World J Gastroenterol. 2010 Jul 28;16(28):3567-72.

9.

Infectious complications after gastric cancer surgery accelerate a rapid hepatic recurrence.

Ohtsuka T, Kitajima Y, Takahashi T, Sato S, Miyoshi A, Kohya N, Kitahara K, Nakafusa Y, Miyazaki K.

Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1277-80.

PMID:
19950777
10.

[A case of unresectable hilar bile duct cancer responding to chemo-radiotherapy by gemcitabine].

Kohya N, Hashiguchi K, Yakabe T, Miyoshi A, Ohtsuka T, Kitahara K, Miyazaki K.

Gan To Kagaku Ryoho. 2009 Oct;36(10):1753-5. Japanese.

PMID:
19838042
11.

A long-time survivor of alpha-fetoprotein-producing gastric cancer successfully treated by fluoropyrimidine-based chemotherapy: a case study.

Hiraki M, Sato S, Kai K, Ohtsuka T, Kohya N, Kitajima Y, Nakafusa Y, Tokunaga O, Miyazaki K.

Clin J Gastroenterol. 2009 Oct;2(5):331-337. doi: 10.1007/s12328-009-0105-9. Epub 2009 Sep 9.

PMID:
26192608
12.

Efficacy of major hepatectomy for large hepatocellular carcinoma.

Miyoshi A, Takahashi T, Otsuka T, Kohya N, Miyazaki K.

Hepatogastroenterology. 2009 May-Jun;56(91-92):768-72.

PMID:
19621699
13.

Improvement of glucose metabolism after a pancreatoduodenectomy.

Ohtsuka T, Kitahara K, Kohya N, Miyoshi A, Miyazaki K.

Pancreas. 2009 Aug;38(6):700-5. doi: 10.1097/MPA.0b013e3181a7c916.

PMID:
19506534
14.

Phase I/II study of combination therapy with S-1 and CPT-11 for metastatic colorectal cancer.

Nakafusa Y, Tanaka M, Ohtsuka T, Miyoshi A, Kohya N, Kitajima Y, Sato S, Mochinaga S, Dohi S, Miyazaki K.

Mol Med Rep. 2008 Nov-Dec;1(6):925-30. doi: 10.3892/mmr_00000051.

PMID:
21479507
15.

Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma.

Ohtaka K, Kohya N, Sato K, Kitajima Y, Ide T, Mitsuno M, Miyazaki K.

Oncol Rep. 2008 Aug;20(2):279-86.

PMID:
18636187
16.

Percutaneous transhepatic portal embolization for persistent bile leakage after hepatic resection: report of a case.

Sadakari Y, Miyoshi A, Ohtsuka T, Kohya N, Takahashi T, Matsumoto K, Miyazaki K.

Surg Today. 2008;38(7):668-71. doi: 10.1007/s00595-007-3667-5. Epub 2008 Jul 9.

PMID:
18612797
17.

Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma.

Kohya N, Miyazaki K.

J Surg Oncol. 2008 May 1;97(6):498-502. doi: 10.1002/jso.20982.

PMID:
18314875
18.

CPT-11 (SN-38) chemotherapy may be selectively applicable to biliary tract cancer with low hMLH1 expression.

Sato K, Kitajima Y, Kohya N, Koga Y, Ohtaka K, Miyazaki K.

Anticancer Res. 2007 Mar-Apr;27(2):865-72.

19.

Aberrant promoter hypermethylation in biliary tract carcinoma.

Kohya N, Koga Y, Kitajima Y, Miyazaki K.

J Hepatobiliary Pancreat Surg. 2006;13(4):296-305. Review.

PMID:
16858540
20.

FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences.

Canaan A, Yu X, Booth CJ, Lian J, Lazar I, Gamfi SL, Castille K, Kohya N, Nakayama Y, Liu YC, Eynon E, Flavell R, Weissman SM.

Mol Cell Biol. 2006 Jul;26(13):5180-9.

21.

Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest.

Sato K, Kitajima Y, Kohya N, Miyoshi A, Koga Y, Miyazaki K.

Int J Oncol. 2005 Jun;26(6):1653-61.

PMID:
15870882
22.

Lineage specificity of gene expression patterns.

Kluger Y, Tuck DP, Chang JT, Nakayama Y, Poddar R, Kohya N, Lian Z, Ben Nasr A, Halaban HR, Krause DS, Zhang X, Newburger PE, Weissman SM.

Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6508-13. Epub 2004 Apr 19.

23.
25.

Deficient expression of O(6)-methylguanine-DNA methyltransferase combined with mismatch-repair proteins hMLH1 and hMSH2 is related to poor prognosis in human biliary tract carcinoma.

Kohya N, Miyazaki K, Matsukura S, Yakushiji H, Kitajima Y, Kitahara K, Fukuhara M, Nakabeppu Y, Sekiguchi M.

Ann Surg Oncol. 2002 May;9(4):371-9.

PMID:
11986189

Supplemental Content

Support Center